Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,695.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (0.15%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

AGM Alternative Arrangements

24 Apr 2020 08:59

RNS Number : 7887K
Spirax-Sarco Engineering PLC
24 April 2020
Β 

Β 

Β 

Β 

Β 

24th April 2020

AGM Alternative Arrangements

Β 

Β 

Spirax-SarcoΒ Engineering plc, theΒ worldΒ leader inΒ thermal energy management, peristaltic pumping and associated fluid path technologies, today announces the following arrangements for its Annual General Meeting to be held on Wednesday, 13th May 2020 at 1400 hrs (AGM).

Β 

In our Circular to Shareholders and Notice of AGM issued on 26th March 2020, we highlighted that we may hold our AGM via a combination of both attendance and conference call/audio webcast to comply with the UK Government measures and laws designed to reduce the transmission of COVID-19. These laws and mandatory measures prohibit, amongst other things, individuals engaging in non-essential travel and public gatherings of more than two people, save where the gathering is essential for work purposes. In order to ensure shareholders can comply with the Stay at Home Measures, the Board has concluded that shareholders will not be able to gain access to the AGM in person on the day. In order to comply with the legal requirements for holding the AGM, a quorum will be constituted by those Directors/employee shareholders in attendance who will observe social distancing measures.

Despite these necessary changes to the format of the AGM, as we stated in the Circular and Notice, it is vital that we achieve the right balance between acting responsibly and accountability.

To ensure that shareholders have an opportunity to engage with the Board, we have put in place a dial-in facility for shareholders wishing to participate using the following telephone number: +44 (0)20 3478 5289. A passcode is required, which can be obtained by contacting us at the email address below. Shareholders dialling into the AGM will be able to speak or ask questions at the start of the meetingΒ relating directly and only to the resolutions and the business of the meeting.

The results of the votes on the proposed resolutions will be announced in the normal way as soon as practicable after the conclusion of the AGM.

In order to ensure that shareholders' votes are counted, the Board strongly encourages shareholders to exercise their right to vote by appointing the Chair of the AGM as their proxy to exercise their right to vote at the AGM in accordance with their instructions. Shareholders can do this by submitting their Form of Proxy and are encouraged to do so online. Simply go to www.sharevote.co.ukΒ and follow the instructions.

Β 

Proxy appointments should be provided as soon as possible and must, as we stated in our Circular to Shareholders and Notice of AGM, be received by Equiniti no later than 1400 hrs on Monday, 11th May 2020 in order to be valid.

Β 

We would like to thank shareholders for their understanding and cooperation in enabling the Company to go ahead with the AGM and comply with the UK Government's compulsory measures in these challenging times.

Β 

Enquiries:

Andrew Robson

Group General Counsel and Company Secretary

Tel: 01242Β 535194

company.secretary@uk.spiraxsarco.com

Β 

Β 

Β 

Β 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow Fluid Technology Group provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies.

Β 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs over 8,000 people, of whom over 1,600 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 Index.

Β 

Further information can be found at www.spiraxsarcoengineering.com

Β 

RNS filter: Inside information prior to release

Β 

LEI 213800WFVZQMHOZP2W17

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCGRGDSISDDGGS
Date   Source Headline
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSChange in Director Details
22nd Apr 20253:52 pmRNSDirector/PDMR Shareholding
11th Apr 20255:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.